Phase I Study of Duvelisib in CLL/SLL #ASH19 #ASH @DanaFarber

Jennifer Crombie, MD of @DanaFarber discusses a phase I study of duvelisib and venetoclax in patients with relapsed or refractory CLL / SLL.